"PAI is a market leader in RTU oral liquid medicines, and that same focus on quality, reliability, and patient-centric design carries naturally into RTU injectables," said Kurt Orlofski, CEO of PAI ...
Enable Injections closed a $215 million Series C financing in January 2022 led by Magnetar Capital, including Sanofi and multiple additional new institutional investors. Enable received significant ...
WILMINGTON, DE & WHIPPANY, NJ — The Noramco Group has announced a $25 million investment to expand its Halo Pharma facility ...
The investment includes the installation of a high-speed, state-of-the-art Groninger UFVN FlexFill syringe, cartridge, and vial filling line and a SKAN isolator to enhance production efficiency and ...
Simtra positioned to become the first CDMO to offer commercial-scale drug product manufacturing of antibody-drug conjugates (ADCs) in the United States, enabling customers to complete the entire ...
The two companies intend to leverage their complementary expertise and technology to bring a novel long acting injectable and drug product manufacturing platform to market. SACRAMENTO, Calif., Aug. 12 ...
In today’s competitive and environmentally-conscious manufacturing landscape, companies are increasingly seeking innovative solutions that improve efficiency, reduce waste, and enhance sustainability.